Business Description
Founded in Copenhagen in 1998, Genmab is a Danish biotechnology company focused on developing antibody-based treatments for cancer and other serious diseases. Its commercial portfolio includes therapies for blood cancers such as large B-cell lymphoma, multiple myeloma, and cervical cancer, among others. The company has a broad pipeline of treatments in development targeting a range of solid tumors and blood disorders, and works alongside major pharmaceutical partners including Johnson & Johnson, Pfizer, AbbVie, and Bristol Myers Squibb.
